-
Abiomed (Danvers, Massachusetts) last month rolled out plans to develop a new line of ventricular-assist devices, suggesting both a return to its initial development effort and an inflection point in its progress with the AbioCor replacement heart program.
-
AST Products (Billerica, Massachusetts), a developer of water-based coatings for medical devices, has completed a licensing agreement with MicroPort Medical (Shanghai, China) for its LubriLAST coating.
-
Women who undergo open-heart surgery are more likely than men to develop acute renal failure (ARF), according to research conducted at The Cleveland Clinic (Cleveland, Ohio).
-
Senior management at CryoCath Technologies (Montreal, Quebec) was elated over the result of an FDA advisory panel meeting last month, despite a list of conditions the company must now address.
-
In one of the more bizarre stories of the year, the FDA has uncovered files of counterfeit Procrit (epoetin alfaJohnson & Johnson) in routine surveillance.
-
The true function of the meniscofemoral ligaments remains unclear, but it may have profound implications for treatment of PCL-deficient knees and lateral meniscal tears.
-
ACL braces were least effective in controlling abnormal knee laxity during the transition from nonweight bearing to weight bearing.
-
A randomized, prospective study found equivalent clinical outcomes for articular cartilage defects treated with either osteochondral plug grafts or autologous chondrocyte implantation (ACI). ACI improvement took longer, and the histology revealed mainly fibrocartilage, calling into question any advantage to this technique.
-
-
Although both grafts yielded acceptable results in a large literature meta-analysis, patellar tendon grafts tended to result in slightly more stable knees with a lower failure rate but at the expense of higher complications and anterior knee pain.
